-+ 0.00%
-+ 0.00%
-+ 0.00%

On September 8, Sandoz announced plans to invest about 300 million US dollars to build a new biosimilar API production facility in Ljubljana, Slovenia, which is expected to be put into operation in 2029. The new facility will use batch technology for disposable supplements to increase the production capacity of 8,000 liters of biopharmaceutical APIs through 4 reactors.

Zhitongcaijing·09/08/2026 05:25:06
Listen to the news
On September 8, Sandoz announced plans to invest about 300 million US dollars to build a new biosimilar API production facility in Ljubljana, Slovenia, which is expected to be put into operation in 2029. The new facility will use batch technology for disposable supplements to increase the production capacity of 8,000 liters of biopharmaceutical APIs through 4 reactors.